Selected Recent Cross-Border Transactions

in its response to an acquisition approach by

Feb 2021
€11.3 billion

in its acquisition of

Feb 2021
$7.2 billion

in its acquisition of reorganized Speedcast International Limited and its affiliates pursuant to a Chapter 11 plan

Jan 2021
$500 million

in its agreement to be acquired by

Jan 2021
$4.6 billion

in its acquisition of

Jan 2021
€1.24 billion

in the sale of its commercial, clinical and research-stage oncology portfolio to

Dec 2020
$2 billion

in its acquisition by

Dec 2020
$39 billion

in its all-stock merger with

Nov 2020
$44 billion

in its Up-C transaction with its shareholders,

Nov 2020

in its acquisition of

Nov 2020
$2.75 billion

in its agreement to acquire

Nov 2020
$11.6 billion

in its acquisition by

Nov 2020
$1.35 billion
Page 3 of 9